Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1992-02-25
1994-04-26
Fay, Zohreh A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514549, 514552, 514912, A61K 3122, A61K 3123
Patent
active
053067290
ABSTRACT:
The invention provides a novel method of effecting vasodilation in a warm-blooded animal in need of such treatment and involves administering to a warm-blooded animal an effective amount of a vasodilatory monoglyceride of the formula: ##STR1## wherein R is a straight or branched chain aliphatic hydrocarbyl substituent of 2-7 carbon atoms, preferably 3-5 carbon atoms, which is saturated or unsaturated, and which is substituted or unsubstituted with one or more substituents that do not interfere with vasodilatory activity.
REFERENCES:
Dobson et al., "1-Butyryl-Glycerol: A Novel Angiogenesis Factor Secreted by Differentiating Adipocytes", Cell, 61:223-230 (Apr. 20, 1990.
Wilkinson et al., "Biosynthetic Regulation of Monobutyrin, an Adipocyte-secreted Lipid with Angiogenic Activity", Journal Biol. Chem., 266:16886-16891 (Sep. 5, 1991.
Birkhahn et al., "Intravenous feeding of the rat with short chain fatty acid esters", The American Journal of Clinical Nurtrition, 30:2078-2082 (Dec. 1977).
White et al., "Identification of Capric Acid as a Potent Vasorelaxant of Human Basilar Arteries", Stroke, 22:469-476 (Apr. 1991).
White et al., "Capric Acid As A Potent Dilator Of Canine Vessels In Vitro and In Vivo", Gen. Pharmac., 22:741-748 (1991).
Prewitt et al., "Antihypertensive Polar Renomedullary Lipid, A Semisynthetic Vasodilator", Hypertension, 1:299-308 (May-Jun. 1979).
Muirhead et al., "Cardiovascular effects of antihypertensive renomedullary lipids (APRL and ANRL)", Acta Physiol. Scand., 117:465-467 (1983).
Muirhead et al., "Cardiovascular Effects of Antihypertensive Polar and Neutral Renomedullary Lipids", Hypertension, Supp. I, 5:I-112-118 (Mar.-Apr. 1983).
Faber et al., "Regional Hemodynamic Effects of Antihyper-tensive Renomedullary Lipids in Conscious Rats", Hypertension, 6:495-501 (Jul.-Aug. 1984).
Muirhead et al., "The Antihypertensive Function of the Kidney; Its Elucidation by Captopril plus Unclipping", Hypertension, Supp. I, 7:I-127-135 (May-Jun. 1985).
Muirhead et al., "Biologic Contrasts Between Medullipin I and Vasoactive Glyceryl Compounds", Amer. Jour. Med. Sci., 298:93-103 (Aug. 1989).
Muirhead et al., "Secretion Of Medullipin I By Isolated Kidneys Perfused Under Elevated Pressure", Clinical and Experimental Pharmacology and Physiology, 18:409-417 (1991).
Muirhead et al., "Antihypertensive Action of Medullipin I Given by Mouth", Hypertension, 17:1092-1096 (Jun. 1991).
Okumura et al., "Effect Of Monoglycerides On The Percutaneous Absorption Of Papaverine Hydrochloride", Drug Design and Delivery, 6:137-148 (1990).
Bursell Sven
Spiegelman Bruce M.
Wilkison William O.
Dana-Farber Cancer Institute
Fay Zohreh A.
Hart Julia D.
Joslin Diabetes Center
LandOfFree
Method for effecting vasodilation with monoglycerides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for effecting vasodilation with monoglycerides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for effecting vasodilation with monoglycerides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1712011